Silence Therapeutics (SLN) Receivables Refunds: 2019-2024
Historic Receivables Refunds for Silence Therapeutics (SLN) over the last 4 years, with Dec 2024 value amounting to $1.5 million.
- Silence Therapeutics' Receivables Refunds rose 23.69% to $1.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.5 million, marking a year-over-year increase of 23.69%. This contributed to the annual value of $1.5 million for FY2024, which is 23.69% up from last year.
- Latest data reveals that Silence Therapeutics reported Receivables Refunds of $1.5 million as of Q4 2024, which was down 92.72% from $21.1 million recorded in Q3 2024.
- In the past 5 years, Silence Therapeutics' Receivables Refunds ranged from a high of $21.1 million in Q3 2024 and a low of $1.2 million during Q4 2023.
- Over the past 3 years, Silence Therapeutics' median Receivables Refunds value was $12.6 million (recorded in 2022), while the average stood at $11.4 million.
- Its Receivables Refunds has fluctuated over the past 5 years, first spiked by 151.29% in 2022, then crashed by 92.87% in 2023.
- Over the past 5 years, Silence Therapeutics' Receivables Refunds (Quarterly) stood at $4.7 million in 2020, then surged by 100.43% to $9.4 million in 2021, then surged by 86.32% to $17.5 million in 2022, then slumped by 92.87% to $1.2 million in 2023, then climbed by 23.69% to $1.5 million in 2024.
- Its Receivables Refunds was $1.5 million in Q4 2024, compared to $21.1 million in Q3 2024 and $16.2 million in Q2 2024.